Cytomegalovirus (CMV) Antibodies Panel (IGG IGM)
Understanding Cytomegalovirus (CMV) Antibodies Panel (IGG IGM)
What is Cytomegalovirus (CMV) Antibodies Panel (IGG IGM)?
The Cytomegalovirus (CMV) Antibodies Panel (IGG IGM) is a set of blood tests done to detect the presence of immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies against Cytomegalovirus (CMV). This test helps determine the stage of the infection, differentiate between recent (acute) and past (chronic) CMV infections, and aid in the timely management of the infection.
Cytomegalovirus (CMV) is a common virus that usually causes mild or no symptoms. In some cases, mild illness may present with nonspecific symptoms like sore throat, fever, tiredness, and swollen glands. Occasionally, otherwise healthy individuals may experience flu-like symptoms such as extreme fatigue, fever, chills, body aches, or headaches, usually resolving within a few weeks. Many individuals may not be aware of their CMV infection as it typically does not cause problems in healthy individuals.
CMV infection can pose serious risks to certain populations, such as pregnant women and individuals with weak immune systems. Once infected, the body retains the virus for life without causing any symptoms. After the initial “primary” infection resolves, CMV becomes dormant or latent. However, if your immune system is significantly weakened, the virus can become active again (reactivate) and cause illness.
The Cytomegalovirus (CMV) Antibodies Panel (IGG IGM) measures two types of antibodies: Immunoglobulin G (IgG) and Immunoglobulin M (IgM) which are produced as an immune response against CMV. Typically, IgM antibodies are the first responders, indicating recent CMV infection. However, IgM antibodies can also appear in cases of secondary (reactivated) CMV infection. On the other hand, IgG antibodies are produced several weeks after the initial CMV infection, indicating a past infection.
This panel is typically advised during pregnancy, especially if there are concerns about congenital abnormalities, unexplained jaundice or anemia in a newborn, or if an infant has seizures or developmental problems related to CMV. Additionally, It is done as a part of the TORCH (Toxoplasmosis(T), Rubella(R), Cytomegalovirus(C), and Herpes Simplex (H) virus infections) panel, a group of tests that screen for several infections that can potentially affect a growing baby during pregnancy. Moreover, this test is recommended for individuals undergoing organ transplants, those with weak immune systems, and when symptoms indicating a potential CMV infection are observed.
Currently, there is no approved vaccine for CMV infection. Early detection and effective treatment are crucial to managing the condition and preventing serious complications in those most at risk of CMV infection.
No special preparation is required before undergoing a Cytomegalovirus (CMV) Antibodies Panel (IGG IGM) test. However, it is important to inform your doctor about any medications, supplements or medical conditions before the test as these factors may potentially influence the test results.
Lab test results may vary across different laboratories. Abnormal test results require an expert interpretation; therefore, never try to self-medicate at home based solely on these results, and always consult a doctor for a proper understanding of the test results.The insights from this test helps the doctor tailor appropriate treatment plan.
What is Cytomegalovirus (CMV) Antibodies Panel (IGG IGM) used for?
The Cytomegalovirus (CMV) Antibodies Panel (IGG IGM) is done:
- To confirm the diagnosis of CMV infection in individuals with suggestive symptoms.
- To find out if an individual has recently (active) or previously (in the past) been exposed to CMV infection.
- In individuals exhibiting symptoms of CMV infection.
- As a part of TORCH panel or prenatal screening to identify recent CMV infection in pregnant women.
- In newborn babies showing symptoms or complications associated with congenital CMV infection.
- In immunocompromised individuals with weak immune system, or those undergoing organ transplant to monitor CMV infection.
What does Cytomegalovirus (CMV) Antibodies Panel (IGG IGM) measure?
Contains 2 testsThe Cytomegalovirus (CMV) Antibodies Panel (IGG IGM) is a set of blood tests used to measure two types of antibodies: Immunoglobulin G (IgG) and Immunoglobulin M (IgM) against cytomegalovirus (CMV). IgM antibodies appear in the blood within a week or two after initial CMV exposure and indicate a recent or ongoing infection. They rise quickly, then decline and usually become undetectable after a few months, but can rise again if the latent virus reactivates. In contrast, IgG antibodies develop several weeks after initial infection and remain detectable for life, indicating past exposure and immunity.
By identifying these antibodies, this test helps determine if an individual has been exposed to the virus and distinguishes between new and existing infections.
Cytomegalovirus IgG Antibody
A Cytomegalovirus IgG Antibody test measures the presence of IgG antibodies in the blood, indicating a previous CMV infection. IgG antibodies are produced several weeks after the initial CMV infection. IgG levels rise during the active infection, then stabilize as the CMV infection resolves and the virus becomes inactive. Once exposed to CMV, you will have some measurable amount of CMV IgG antibody in your blood for the rest of your life, which provides protection from getting another primary infection (immunity). However, if you have a weak immune system, the virus can reactivate and cause serious symptoms or organ damage.
Know more about Cytomegalovirus IgG Antibody
Cytomegalovirus IgM Antibody
A Cytomegalovirus IgM Antibody test measures the presence of Immunoglobulin M (IgM) antibodies in the blood, specifically targeting the CMV. IgM antibodies are produced by the body first in response to a CMV infection. They can be detected in the blood within a week or two after the initial exposure. IgM levels rise for a short time, then decline and usually fall below detectable levels after a few months. IgM antibody levels rise again when latent CMV is reactivated.
Elevated levels of CMV IgM antibodies indicate an ongoing infection or recent exposure to the virus. Understanding the presence of IgM antibodies helps doctors diagnose and manage CMV infections effectively.
Know more about Cytomegalovirus IgM Antibody
Answers to Patient Concerns & Frequently Asked Questions (FAQs) about Cytomegalovirus (CMV) Antibodies Panel (IGG IGM)
Frequently Asked Questions about Cytomegalovirus (CMV) Antibodies Panel (IGG IGM)
Q. What is the Cytomegalovirus (CMV) Antibodies Panel (IGG IGM)?
Q. Why might I need the Cytomegalovirus (CMV) Antibodies Panel (IGG IGM)?
Q. How is the Cytomegalovirus (CMV) Antibodies Panel (IGG IGM) performed?
Q. Is there any risk associated with the Cytomegalovirus (CMV) Antibodies Panel (IGG IGM)?
Q. What happens if my CMV IgM antibody test result is positive?
Q. What if my CMV IgG antibody test result is positive?
Q. Can you get a CMV infection twice?
Q. Can the CMV IgM test be used to monitor my treatment for CMV?
Q. How is CMV infection transmitted?
Q. How can CMV infection affect a pregnancy?
Q. What birth defects can be caused by CMV infection?
Q. How does Tata 1mg ensure accurate lab test results?
Book a Cytomegalovirus (CMV) Antibodies Panel (IGG IGM) test at home near me
References
- About Cytomegalovirus (CMV) [Internet]. CDC; 18 Aug. 2020 [Accessed 22 Aug. 2024]. Available from: https://www.cdc.gov/cmv/overview.html
- Cytomegalovirus (Blood) [Internet]. Rochester, NY: University of Rochester Medical Center; [Accessed 22 Aug. 2024]. Available from: https://www.urmc.rochester.edu/encyclopedia/content.aspx?contenttypeid=167&contentid=cytomegalovirus_blood
- Gupta M, Shorman M. Cytomegalovirus. [Updated 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459185/
- Akpan US, Pillarisetty LS. Congenital Cytomegalovirus Infection. [Updated 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK541003/
- Ross SA, Novak Z, Pati S, Boppana SB. Overview of the diagnosis of cytomegalovirus infection. Infect Disord Drug Targets. 2011 Oct;11(5):466-74. [Accessed 22 Aug. 2024]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730495/
- Udeze A, Odebisi-Omokanye M, Ajileye T. Cytomegalovirus infection among Human Immunodeficiency Virus (HIV) infected individuals on highly active anti-retroviral therapy in North-Central Nigeria. Afr Health Sci. 2018 Dec;18(4):1057-1065. [Accessed 22 Aug 2024]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354892/
- Lazzarotto T, Ripalti A, Bergamini G, Battista MC, Spezzacatena P, Campanini F, Pradelli P, Varani S, Gabrielli L, Maine GT, Landini MP. Development of a new cytomegalovirus (CMV) immunoglobulin M (IgM) immunoblot for detection of CMV-specific IgM. J Clin Microbiol. 1998 Nov;36(11):3337-41. [Accessed 22 Aug. 2024]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC105325/#:~:text=Cytomegalovirus%20(CMV)%2Dspecific%20immunoglobulin,33%2C%2035%2C%2036).
- Munro SC, Hall B, Whybin LR, Leader L, Robertson P, Maine GT, Rawlinson WD. Diagnosis of and screening for cytomegalovirus infection in pregnant women. J Clin Microbiol. 2005 Sep;43(9):4713-8. [Accessed 22 Aug. 2024]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1234061/#:~:text=CMV%20IgM%20has%20been%20shown,used%20(11%2C%2043).
Other tests
